Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug delivery
Biotech
Oncology biotech licenses Genevant tech for up to $123M
The goal of the deal is to develop new mRNA-lipid nanoparticle therapies for an undisclosed cancer indication.
Darren Incorvaia
Dec 20, 2024 6:00am
2 biotechs shed staff, fuse to form genetic medicine company
Dec 11, 2024 7:00am
AI-powered Insitro taps Lilly to clear path to clinic for siRNA
Oct 9, 2024 9:28am
BD plans to surf GLP-1 wave to a $1B drug delivery biz by 2030
Aug 1, 2024 11:30am
A brain parasite has been turned into drug delivery system
Jul 29, 2024 2:55pm
Tiba wins BARDA contract to develop RNAi flu therapeutics
Jul 11, 2024 3:35pm
